Indian Pharmas Gaining On MNCs In New Patent Era
This article was originally published in PharmAsia News
Executive Summary
The fear that global companies would squeeze India's drug making industry has proved to be unfounded. Instead, multinational corporations have lost market shares within the past three years since new patent regulations were adopted. Losing MNCs include top 10-ranked firms such as Pfizer and GlaxoSmithKline. Gainers during the same period were led by India's Cipla and Ranbaxy Laboratories, both among India's top 10 pharmas. Some experts caution, however, that India's patent policy is still in its nascent stage. (Click here for more